Massive data dive to map Germany's eye health
NCT ID NCT07308639
Summary
This study aims to understand how common three serious eye diseases are in Germany and how treatment patterns have changed. Researchers will analyze existing health records from 50,000 people collected between 2009 and 2024. The goal is to map the occurrence of these diseases and see how many patients received a common sight-saving medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD); DIABETIC MACULAR EDEMA (DME); RETINAL VEIN OCCLUSION (RVO) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bayer Vital GmbH
Leverkusen, 51373, Germany
Conditions
Explore the condition pages connected to this study.